Search research articles
Contact Us
Filters
Showing results (881-890 of 957) with videos related to
Page
of 96
Sort By:
Cell Reports. Medicine
|
February 2, 2024
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
Yan Li, Renee B Chang, Meredith L Stone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood
David C Qian, Bryan C Ulrich, Gang Peng, et al.
Genes, Brain, and Behavior
|
July 19, 2011
Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population
C-F Pasaje, J-S Bae, B-L Park, et al.
Cancer
|
August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck
Nabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure
Ashley L Kiemen, Cristina Almagro-Pérez, Valentina Matos, et al.
Cancer
|
October 21, 2017
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma
Frederico O Gleber-Netto, Mei Zhao, Sanchit Trivedi, et al.
Archives of Dermatological Research
|
May 17, 2024
Antibiotic adherence in dermatologic surgery: a Multicenter prospective cohort study
Surya A Veerabagu, Leora Aizman, Brian Cheng, et al.
Cancer
|
December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
J E Tseng, B S Glisson, F R Khuri, et al.
Cancer Immunology Research
|
January 12, 2026
A randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDAC
Katherine M Bever, Amanda L Huff, Ludmila Danilova, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer
André Forjaz, Hengameh Mojdeganlou, Alens Valentin, et al.
Page
of 96
Search research articles
Search
Showing results (881-890 of 957) with videos related to
Sort By:
Page
of 96
Cell Reports. Medicine
|
February 2, 2024
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
Yan Li, Renee B Chang, Meredith L Stone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood
David C Qian, Bryan C Ulrich, Gang Peng, et al.
Genes, Brain, and Behavior
|
July 19, 2011
Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population
C-F Pasaje, J-S Bae, B-L Park, et al.
Cancer
|
August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck
Nabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure
Ashley L Kiemen, Cristina Almagro-Pérez, Valentina Matos, et al.
Cancer
|
October 21, 2017
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma
Frederico O Gleber-Netto, Mei Zhao, Sanchit Trivedi, et al.
Archives of Dermatological Research
|
May 17, 2024
Antibiotic adherence in dermatologic surgery: a Multicenter prospective cohort study
Surya A Veerabagu, Leora Aizman, Brian Cheng, et al.
Cancer
|
December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
J E Tseng, B S Glisson, F R Khuri, et al.
Cancer Immunology Research
|
January 12, 2026
A randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDAC
Katherine M Bever, Amanda L Huff, Ludmila Danilova, et al.
Biorxiv : the Preprint Server for Biology
|
March 23, 2026
Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer
André Forjaz, Hengameh Mojdeganlou, Alens Valentin, et al.
Page
of 96